Company
United StatesPublic company, NYSE: MCKMcKesson Corporation Headquarters (NYSE: MCK), San Francisco, CA – FDA Inspections
Inspection records and compliance data for McKesson Corporation Headquarters in San Francisco, CA. 1 FDA inspection on record, 1 Form 483, last inspected July 18, 2018. Publicly traded as NYSE: MCK.
Company Profile
This profile covers McKesson Corporation Headquarters based in San Francisco, CA, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected July 18, 2018.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 18, 2018 | Not classified | Human Drugs | 1060476 |
FDA documents
Form 483s (1)
People (2)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
McKesson Corporation Headquarters
Stock ticker
MCK
Exchange
NYSE
Share price
$1,077.78
Market cap
$124.4B
Price as of
November 13, 2026
FEI Number
3014548060
Address
1 Post St, San Francisco, CA 94104, United States
Country
United States
ID: 0965d62f-b1cd-40c8-959c-7be2fb9456c9